Related Experiment Video
Updated: Apr 21, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
A clearer view of the molecular complexity of clear cell renal cell carcinoma
1Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zurich CH-8057, Switzerland;
Abstract:
The von Hippel-Lindau (VHL) tumor suppressor gene is mutated as an early event in almost all cases of clear cell renal cell carcinoma (ccRCC), the most frequent form of kidney cancer. In this review we discuss recent advances in understanding how dysregulation of the many hypoxia-inducible factor α-dependent and -independent functions of the VHL tumor suppressor protein (pVHL) can contribute to tumor initiation and progression. Recent evidence showing extensive inter- and intratumoral genetic diversity has given rise to the idea that ccRCC should actually be considered as a series of molecularly related, yet distinct, diseases defined by the pattern of combinatorial genetic alterations present within the cells of the tumor. We highlight the range of genetic and epigenetic alterations that recur in ccRCC and discuss the mechanisms through which these events appear to function cooperatively with a loss of pVHL function in tumorigenesis.
Insights
The von Hippel-Lindau (VHL) gene mutation drives clear cell renal cell carcinoma (ccRCC). Understanding VHL protein (pVHL) functions and tumor genetic diversity is key to ccRCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer.
- The von Hippel-Lindau (VHL) tumor suppressor gene is frequently mutated early in ccRCC development.
Purpose of the Study:
- To review recent advances in understanding VHL tumor suppressor protein (pVHL) functions.
- To explore how VHL dysregulation contributes to ccRCC initiation and progression.
- To discuss the role of genetic and epigenetic alterations in ccRCC.
Main Methods:
- Review of recent scientific literature on VHL and ccRCC.
- Analysis of genetic and epigenetic alterations in ccRCC tumors.
- Discussion of VHL protein functions and their impact on tumorigenesis.
Main Results:
- VHL gene mutations are an early event in most ccRCC cases.
- pVHL has multiple hypoxia-inducible factor α-dependent and -independent functions.
- ccRCC exhibits extensive inter- and intratumoral genetic diversity, suggesting distinct molecular subtypes.
- Genetic and epigenetic alterations cooperate with loss of pVHL function in ccRCC development.
Conclusions:
- Dysregulation of pVHL contributes significantly to ccRCC initiation and progression.
- ccRCC can be viewed as a spectrum of diseases defined by specific genetic alteration patterns.
- Further research into these alterations is crucial for targeted ccRCC therapies.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

